Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001415889-21-002208)

Filing Details

Accession Number:
0001415889-21-002208
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-29 21:37:39
Reporting Period:
2021-04-29
Accepted Time:
2021-04-29 21:37:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411906 Ampio Pharmaceuticals Inc. AMPE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1109775 H Philip Coelho C/O Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Suite 200
Englewood CO 80112		 No No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-29 3,263 $0.40 206,763 No 4 M Direct
Common Stock Disposition 2021-04-29 3,263 $2.00 203,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-04-29 3,263 $0.40 3,263 $0.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,737 2028-12-15 No 4 M Direct
Footnotes
  1. The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 30, 2021.
  2. Options were granted and previously reported on a Form 4 filed on January 9, 2019, where the stock option vested and became exercisable in 12 equal monthly installments from the date of grant of December 15, 2018.